Physiological research, 51(1), 9398
Its novel dual mechanism of action establishes tirzepatide as a first-in-class GLP-1/GIP and a strong contender against competitors in the T2D market, said Jesse Cuaron, director of cardiovascular and metabolic disease (CVMD) and gender health at GlobalData
Semaglutide is a well-known GLP-1 receptor agonist, and tirzepatide also acts on GLP-1 receptors but has an additional benefit of working on GIP receptors, which are another part of how the body manages blood sugar
Lancet , 398(10317), 21602172
Biomechanics research confirms that restricted ankle dorsiflexion and tight calf musculature are among the strongest predictors of plantar fasciitis recurrence
Fetal Bovine Serum (04-001-1ACS), Trypsin EDTA solution (03-050-1A), and RPMI Medium 1640 (01-100-1ACS) were purchased from Biological Industries